Tag: investing in Hollister Biosciences
Hollister Provides Comment on Approval of Recreational Cannabis in Arizona
Hollister Biosciences Inc. Provides Update on Q3 2020 Performance
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone
Hollister Biosciences Retains Renmark Financial Communications Inc.
Hollister Biosciences Inc. and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement
Hollister Biosciences Inc. and Allied Corp. sign Definitive Agreement for Veteran Based Brand: Tactical Relief™
Hollister Bioscience’s 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020
